ClinConnect ClinConnect Logo
Search / Trial NCT06025643

Effects of Electrical Nervous Stimulation Transcutaneous in Hypertensive Patients

Launched by FEDERAL UNIVERSITY OF HEALTH SCIENCE OF PORTO ALEGRE · Aug 29, 2023

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring a new way to help manage high blood pressure, also known as hypertension, using a method called Transcutaneous Electrical Nerve Stimulation (TENS). TENS uses low-frequency electrical pulses to stimulate nerves and has been traditionally used to relieve pain. Researchers want to see if applying TENS on different parts of the body can help lower blood pressure and improve heart and blood vessel function in people with hypertension.

To participate in this study, you would need to have a diagnosis of high blood pressure, with specific measurements indicating your levels are above normal. However, there are certain conditions that would exclude you from the trial, such as having a heart condition like congestive heart failure or a cardiac pacemaker. If you decide to join, you’ll be part of a process that aims to find new, non-drug treatments for controlling blood pressure, which could be beneficial for many people in the future. The trial is not yet recruiting participants, so stay tuned for updates if you're interested!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - Diagnosis of systemic arterial hypertension: systolic blood pressure (SBP) ≥ 130 mmHg and diastolic blood pressure (DBP) ≥ 80 mmHg diagnosed by ambulatory blood pressure monitoring (ABPM).
  • Exclusion Criteria:
  • Congestive heart failure
  • Patients with a cardiac pacemaker
  • Previous heart surgery
  • Patients with serum creatinine \>2.5 mg/dL
  • Change in drug therapy in the two months prior to starting the study
  • Active smoking

About Federal University Of Health Science Of Porto Alegre

The Federal University of Health Science of Porto Alegre (UFCSPA) is a distinguished academic institution in Brazil, dedicated to advancing healthcare education, research, and clinical practice. Renowned for its commitment to excellence in medical and health sciences, UFCSPA plays a pivotal role in fostering innovation through rigorous clinical trials and collaborative research initiatives. The university's research programs are designed to address pressing health challenges, enhance patient care, and contribute to the scientific community, ensuring that findings translate into meaningful health solutions. With a multidisciplinary approach and a focus on ethical standards, UFCSPA is at the forefront of improving health outcomes both locally and globally.

Locations

Patients applied

0 patients applied

Trial Officials

Rodrigo DM Plentz, PhD

Principal Investigator

Federal University of Health Sciences of Porto Alegre

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported